Health, risks and disease in therapeutic functionalities of Glucagon-like peptide-1 receptoragonists (GLP-1RAs) concerning human susceptibility. Greenfort International Journal of Applied Medical Science, [S. l.], v. 3, n. 5, p. 240–254, 2025. DOI: 10.62046/gijams.2025.v03i05.002. Disponível em: https://gijams.in/index.php/gijams/article/view/Health-risks-and-disease-in-therapeutic. Acesso em: 10 apr. 2026.